Funds holding JASPER THERAPEUTICS INC
ISIN US4718712023 · United States
- Fund holders
- 14
- Of which ETFs
- 1 13 other funds
- Value held
- 1.4M $
- Share of capital
- 4.5 % of 33.3M shares on Aug 10, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 833,391 | 730.2K $ | 2.50 % | as of Mar 31, 2026 ↗ | |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 312,032 | 273.4K $ | 0.00 % | 0.94 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 142,962 | 197.3K $ | 0.00 % | 0.43 % | as of Feb 28, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 68,218 | 59.8K $ | 0.00 % | 0.21 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 49,896 | 68.9K $ | 0.00 % | 0.15 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 28,948 | 39.9K $ | 0.09 % | as of Feb 28, 2026 ↗ | |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 27,174 | 23.8K $ | 0.08 % | as of Mar 31, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 9,659 | 13.3K $ | 0.00 % | 0.03 % | as of Feb 28, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 4,665 | 4.1K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 3,638 | 3.2K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 2,540 | 2.2K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 781 | 684.3 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AST Small-Cap Equity Portfolio Advanced Series Trust | 780 | 683.4 $ | 0.00 % | as of Mar 31, 2026 ↗ | |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 146 | 136.7 $ | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| iShares Micro-Cap ETF iShares Trust | 0.00 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.00 % | as of Mar 31, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 14 | -3 | 1,484,830 | -20.9 % |
| 2026Q1 | 17 | -7 | 1,876,992 | -20.8 % |
| 2025Q4 | 24 | -27 | 2,368,887 | +67.0 % |
| 2025Q3 | 51 | -37 | 1,418,748 | -36.8 % |
| 2025Q2 | 88 | -9 | 2,244,681 | +13.5 % |
| 2025Q1 | 97 | +5 | 1,977,382 | -3.0 % |
| 2024Q4 | 92 | +49 | 2,039,030 | +56.3 % |
| 2024Q3 | 43 | +25 | 1,304,179 | +27.5 % |
| 2024Q2 | 18 | +16 | 1,023,257 | +590.2 % |
| 2024Q1 | 2 | 148,263 |
Institutional managers
54 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Velan Capital Investment Management LP | 2,668,395 | 2.3M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,617,531 | 1.4M $ | as of Mar 31, 2026 |
| ACORN CAPITAL ADVISORS, LLC | 1,411,492 | 1.2M $ | as of Mar 31, 2026 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,352,106 | 1.2M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,333,420 | 1.2M $ | as of Mar 31, 2026 |
| Rock Springs Capital Management LP | 1,100,726 | 964.5K $ | as of Mar 31, 2026 |
| Carlyle Group Inc. | 1,066,189 | 934.2K $ | as of Mar 31, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | 582,751 | 510.6K $ | as of Mar 31, 2026 |
| Lion Point Capital, LP | 465,000 | 407.4K $ | as of Mar 31, 2026 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 322,273 | 282.4K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 317,677 | 278.4K $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 293,259 | 256.9K $ | as of Mar 31, 2026 |
| Soleus Capital Management, L.P. | 276,312 | 242.1K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 242,061 | 212.1K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 177,500 | 155.5K $ | as of Mar 31, 2026 |
| Knott David M Jr | 160,789 | 140.9K $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 140,000 | 122.7K $ | as of Mar 31, 2026 |
| Quarry LP | 131,529 | 115.2K $ | as of Mar 31, 2026 |
| UBS Group AG | 81,117 | 71.1K $ | as of Mar 31, 2026 |
| Verdad Advisers, LP | 73,967 | 64.8K $ | as of Mar 31, 2026 |
| Squarepoint Ops LLC | 64,915 | 56.9K $ | as of Mar 31, 2026 |
| IEQ CAPITAL, LLC | 51,428 | 45.1K $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 45,656 | 40.2K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 44,699 | 39.2K $ | as of Mar 31, 2026 |
| NINE MASTS CAPITAL Ltd | 44,165 | 38.7K $ | as of Mar 31, 2026 |
Declared shareholders of JASPER THERAPEUTICS INC
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Morgan Stanley and 1 other | 4.80 % | 1,333,420 | as of Mar 31, 2026 · SCHEDULE 13G |
| Soleus Capital Master Fund, L.P. and 8 others | 1.00 % | 276,312 | as of Mar 31, 2026 · SCHEDULE 13G |
| THE GOLDMAN SACHS GROUP, INC. and 1 other | 0.50 % | 128,862 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding JASPER THERAPEUTICS INC". https://titelia.com/en/stocks/jasper-therapeutics-inc-US4718712023